UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Common epidermal growth factor receptor mutations in north Indian patients with non-small cell lung carcinoma: evidence from real-time polymerase chain reaction

Monaldi archives for chest disease, 2024-10

2024

Volltextzugriff (PDF)

An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus

JCI insight, 2021-04, Vol.6 (8)

2021

Volltextzugriff (PDF)

HIV in ICU

Infectious Diseases in the Intensive Care Unit, 2020, p.247-265

2020

Volltextzugriff (PDF)

A multimodal disease modifying approach to treat neuropathic pain - inhibition of soluble epoxide hydrolase (sEH): Post screen

Drug discovery today, 2015-11, Vol.20 (11), p.1382-1390

2015

Volltextzugriff (PDF)

A multimodal disease modifying approach to treat neuropathic pain – inhibition of soluble epoxide hydrolase (sEH)

Drug discovery today, 2015-11, Vol.20 (11), p.1382-1390

2015

Volltextzugriff (PDF)

Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonists

Bioorganic & medicinal chemistry letters, 2015-02, Vol.25 (4), p.887-892

2015

Volltextzugriff (PDF)

Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain

Journal of Pain Research, 2015-01, Vol.8 (Issue 1), p.859-870

2015

Volltextzugriff (PDF)

Central nervous system fungal infections: Observations from a large tertiary hospital in northern India

Clinical neurology and neurosurgery, 2012-11, Vol.114 (9), p.1232-1237

2012

Volltextzugriff (PDF)

Drug discovery in pharmaceutical industry: productivity challenges and trends

Drug discovery today, 2012-10, Vol.17 (19-20), p.1088-1102

Khanna, Ish

2012

Volltextzugriff (PDF)

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Part 2

Bioorganic & medicinal chemistry letters, 2012-05, Vol.22 (9), p.3163-3167

2012

Volltextzugriff (PDF)

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists

Bioorganic & medicinal chemistry letters, 2012-05, Vol.22 (9), p.3157-3162

2012

Volltextzugriff (PDF)

Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors

Inflammation & allergy drug targets, 2012-04, Vol.11 (2), p.143-158

2012

Volltextzugriff (PDF)

Targeting soluble epoxide hydrolase for inflammation and pain - an overview of pharmacology and the inhibitors

Inflammation & allergy drug targets, 2012-04, Vol.11 (2), p.143

2012

Volltextzugriff (PDF)

Fatty acid amide hydrolase inhibitors--progress and potential

CNS & neurological disorders drug targets, 2011-08, Vol.10 (5), p.545-558

2011

Volltextzugriff (PDF)

Synthesis and SAR studies of benzimidazole derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Focus to detune hERG inhibition

MedChemComm, 2011-05, Vol.2 (5), p.385

2011

Volltextzugriff (PDF)

Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists

Bioorganic & medicinal chemistry letters, 2010-09, Vol.20 (18), p.5443-5448

2010

Volltextzugriff (PDF)

Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases

Drug discovery today, 2009-12, Vol.14 (23-24), p.1098-1111

2009

Volltextzugriff (PDF)

Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimization

Bioorganic & medicinal chemistry, 2007-05, Vol.15 (10), p.3390-3412

2007

Volltextzugriff (PDF)

Discovery of + (2 -{4 -[2 -(5,6,7,8 -tetrahydro -1,8 -naphthyridin -2-yl )ethoxy ]phenyl} -cyclopropyl )acetic acid as potent and selective αvβ3 inhibitor : Design, synthesis, and optimization

Bioorganic & medicinal chemistry, 2007-05, Vol.15 (10), p.3390-3412

2007

Volltextzugriff (PDF)

Chapter 12 Recent Trends in HDL Modulating Therapies

Annual Reports in Medicinal Chemistry, 2007, Vol.42, p.177-191

2007

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(40)
Buchkapitel
(2)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Common epidermal growth factor receptor mutations in north Indian patients with non-small cell lung carcinoma: evidence from real-time polymerase chain reaction

An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus

HIV in ICU

A multimodal disease modifying approach to treat neuropathic pain - inhibition of soluble epoxide hydrolase (sEH): Post screen

A multimodal disease modifying approach to treat neuropathic pain – inhibition of soluble epoxide hydrolase (sEH)

Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonists

Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain

Central nervous system fungal infections: Observations from a large tertiary hospital in northern India

Drug discovery in pharmaceutical industry: productivity challenges and trends

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Part 2

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists

Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors

Targeting soluble epoxide hydrolase for inflammation and pain - an overview of pharmacology and the inhibitors

Fatty acid amide hydrolase inhibitors--progress and potential

Synthesis and SAR studies of benzimidazole derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Focus to detune hERG inhibition

Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists

Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases

Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimization

Discovery of + (2 -{4 -[2 -(5,6,7,8 -tetrahydro -1,8 -naphthyridin -2-yl )ethoxy ]phenyl} -cyclopropyl )acetic acid as potent and selective αvβ3 inhibitor : Design, synthesis, and optimization

Chapter 12 Recent Trends in HDL Modulating Therapies

Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective α vβ 3 inhibitor: Design, synthesis, and optimization

Convergent, parallel synthesis of a series of β-substituted 1,2,4-oxadiazole butanoic acids as potent and selective αvβ3 receptor antagonists

Convergent, parallel synthesis of a series of beta-substituted 1,2,4-oxadiazole butanoic acids as potent and selective alpha(v)beta3 receptor antagonists

Convergent, parallel synthesis of a series of beta -substituted 1,2,4- oxadiazole butanoic acids as potent and selective alpha sub(v) beta sub(3) receptor antagonists

Convergent, parallel synthesis of a series of β-substituted 1,2,4-oxadiazole butanoic acids as potent and selective α vβ 3 receptor antagonists

Suchergebnisse filtern